Announced
Completed
Synopsis
Edwards Lifesciences, a provider of science of heart valves and hemodynamic monitoring, completed the acquisition of JenaValve, a medical device company, and Endotronix, a digital health medtech company. Financial terms were not disclosed. “These acquisitions expand our opportunities to address the unmet needs of aortic regurgitation and heart failure patients around the world. We are pleased to enter these structural heart therapeutic areas with innovation, world-class science and clinical evidence to provide access to life-saving technologies for patients around the world,” Bernard Zovighian, Edwards’ CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.